Maximus (NYSE:MMS) Upgraded by StockNews.com to Buy

Maximus (NYSE:MMSGet Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday.

A number of other research analysts have also recently weighed in on the stock. Raymond James cut shares of Maximus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 3rd. TheStreet upgraded shares of Maximus from a “c+” rating to a “b-” rating in a report on Monday, December 4th.

View Our Latest Analysis on Maximus

Maximus Stock Performance

MMS stock traded up $0.83 on Thursday, hitting $78.79. The company had a trading volume of 1,184,565 shares, compared to its average volume of 435,954. Maximus has a 12-month low of $72.39 and a 12-month high of $89.69. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.70. The stock’s 50-day simple moving average is $82.29 and its 200 day simple moving average is $80.14. The stock has a market cap of $4.81 billion, a price-to-earnings ratio of 29.96 and a beta of 0.72.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.06. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 3.30% and a return on equity of 14.46%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.94 EPS. As a group, equities research analysts expect that Maximus will post 5.32 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Ilene R. Baylinson sold 10,043 shares of the stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $85.57, for a total transaction of $859,379.51. Following the transaction, the insider now directly owns 5,002 shares in the company, valued at $428,021.14. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.40% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. PNC Financial Services Group Inc. grew its position in Maximus by 16.3% during the first quarter. PNC Financial Services Group Inc. now owns 2,520 shares of the health services provider’s stock valued at $188,000 after buying an additional 354 shares during the period. Bank of Montreal Can grew its position in Maximus by 9.0% during the first quarter. Bank of Montreal Can now owns 15,203 shares of the health services provider’s stock valued at $1,179,000 after buying an additional 1,255 shares during the period. Panagora Asset Management Inc. grew its position in Maximus by 39.9% during the first quarter. Panagora Asset Management Inc. now owns 4,977 shares of the health services provider’s stock valued at $373,000 after buying an additional 1,419 shares during the period. Rhumbline Advisers grew its position in Maximus by 4.1% during the first quarter. Rhumbline Advisers now owns 242,103 shares of the health services provider’s stock valued at $18,146,000 after buying an additional 9,510 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in Maximus by 11.3% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 22,694 shares of the health services provider’s stock valued at $1,701,000 after buying an additional 2,313 shares during the period. Hedge funds and other institutional investors own 99.30% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.